Omegaven injectable emulsion becomes available in the U.S.
LAKE ZURICH, Ill. — Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced that Omegaven (fish oil triglycerides) injectable emulsion is now commercially available in the United States. This novel lipid had previously been available only for compassionate use in the U.S. Omegaven is an intravenous
